|
|||||
|
|
Rituximab treatment in patients with primary Sjögren's syndrome: An open‐label phase II study |
|
| Authors: | J. Pijpe G. W. van Imhoff F. K. L. Spijkervet J. L. N. Roodenburg G. J. Wolbink K. Mansour A. Vissink C. G. M. Kallenberg H. Bootsma |
| Abstract: | |
| Keywords: | |